Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Pulmatrix, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 12 | 14 | +2 |
| Shares | 334.8K | 345.8K | +11.0K (+3.3%) |
| Value | $2.31M | $1.68M | −$628.8K (−27.2%) |
New holders (4)
Institutions that held Pulmatrix, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 10,780 | $52.5K | 0.00% |
| Northwestern Mutual Wealth Management Co | 7 | $34 | 0.00% |
| Farther Finance Advisors, LLC | 7 | $34 | 0.00% |
| Barclays PLC | 3 | $15 | 0.00% |
Sold out (2)
Institutions that held Pulmatrix, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citigroup Inc | 90 | $621 |
| Raymond James Financial Inc | 1 | $7 |